MiMedx Group - MDXG Quarterly EPS earnings growth

MiMedx Corp - graphic logo of issuer MDXG

Quarterly earnings per share dynamics demonstrate the current growth rates of MiMedx Group, Inc. (MDXG), where the -153.20 mark records this metric. The company competes with synthetic skin developers in the biomaterials niche while facing insurance reimbursement risks. The business relies on partnerships with burn centers to implement placental implants, aiming to scale surgical graft sales and accelerate clinical trials.

MiMedx (MDXG) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/15/2026

Financial and market metric breakdowns for MiMedx Group, Inc. (MDXG)

- share price and consensus valuation forecast:
Stock Quotes MiMedx|MDXG - Analyst Forecast Prices
- issuer market value details:
Market Capitalization MiMedx Corp|MDXG - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share MiMedx|MDXG - Company Book Value|Market Value to Book Value Ratio mimedx.com|MDXG - Company Assets
- debt and liquidity data:
Debt to Equity MiMedx Group, Inc.|MDXG - Long-Term Debt to Equity|Short-Term Debt to Capital MiMedx Group Inc|MDXG - Company Total Debt Obligations|Debt to Book Capitalization Ratio MiMedx Group Inc|MDXG - Long-Term Debt Volume|Company Short-Term Debt MiMedx|Quick Liquidity mimedx.com
- earnings and valuation multiples indicators:
MDXG - Net Income|Projected Future Earnings MiMedx Group, Inc.|MDXG - Business Payback Period|Future Price to Earnings mimedx.com|MDXG - Price/Earnings to Growth Multiple|EV/EBITDA Multiple MiMedx Group|MDXG - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) MiMedx|MDXG - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months mimedx.com|MDXG - Earnings per share growth this year|Expected earnings per share growth for next year MiMedx Group, Inc.
- sales volume and revenue information:
MDXG - Company Sales Revenue|Projected Sales Volume MiMedx Group Inc|MDXG - Price-to-Revenue Multiple|Price-to-Projected Revenue Ratio MiMedx Group, Inc.|MDXG - Revenue Dynamics YoY (Last Twelve Months)
Analysis of all company metrics:MiMedx Group, Inc.
Manufactured product of MiMedx Corp

This indicator measures the quarterly dynamics of earnings per share, reflecting the actual scaling speed of the business. In the case of MiMedx Group, Inc. (MDXG), growth in this metric confirms the commercial efficiency of its patented placental tissue processing technologies. By analyzing the quarterly growth in earnings per share, an investor can see the impact of regulatory barriers on profitability. Sharp spikes in the curve signal the risk of overpayment, while a stable trend confirms the resilience of the issuer's capital.

Competitors of MiMedx Group, Inc. (MDXG)

ASND (Ascendis Pharma) - Year-over-year net earnings per share growth for the last 12 months|MDGL: Year-over-year earnings per share growth rate for the last twelve months|CORT (Corcept Therapeutics Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rhythm Pharmaceuticals|Quarterly EPS earnings growth AKRO|Year-over-year earnings per share growth for the last twelve months MTSR (Metsera, Inc.)|Year-over-year earnings per share growth for the last twelve months moonlaketx.com MLTX|Crinetics Corp (CRNX) - Earnings per share growth in annualized terms for the last twelve months|NAMS - Year-over-year earnings per share growth for the last twelve months|SLNO: Year-over-year earnings per share growth for the last twelve months|FOLD: Quarterly EPS earnings growth|ETNB - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Agios Corp|Structure Corp (GPCR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months rezolutebio.com (RZLT)|Year-over-year net earnings per share growth for the last 12 months lexpharma.com LXRX|Quarterly EPS earnings growth MBX (MBX Biosciences)|Altimmune Corp - Year-over-year earnings per share growth for the last twelve months|Aardvark Therapeutics Inc. - Quarterly EPS earnings growth|SGMT - Quarterly EPS earnings growth|BioAge Labs (BIOA) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months biomeafusion.com (BMEA)|Year-over-year earnings per share growth for the last twelve months Quince Therapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months Fractyl (GUTS)|Year-over-year net earnings per share growth for the last 12 months VTVT (vTv Therapeutics Inc.)|ATPC - Earnings per share growth in annualized terms for the last twelve months|Pluri Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Synlogic Corp|LPCN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Matinas BioPharma Holdings, Inc. MTNB|SPRB: Quarterly EPS earnings growth|Galecto Corp - Year-over-year earnings per one share growth for the last 12 months|CTCX (carmellrx.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth lumos-pharma.com|Quarterly EPS earnings growth ONVO|Year-over-year net earnings per share growth for the last 12 months Radius Health RDUS